XVIVO Q1 2022: From strength to strength - Redeye

The Thoracic recovery continues, and together with well-balanced and high organic growth, we expect the initial soft reaction evolves into value support and continuing structural support even if the general equity market sentiment remains challenging

Länk till analysen i sin helhet: https://www.redeye.se/research/839082/xvivo-q1-2022-from-strength-to-strength?utm_source=finwire&utm_medium=RSS